Now Available! | Check out UMR’s 2024 Annual Economic Report and State Toolkits today
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

MilliporeSigma’s St. Louis workers are on front line of coronavirus fight

In the race to develop drugs and vaccines for COVID-19, MilliporeSigma rarely grabs any headlines, but it’s a critical supplier to companies that do. When you read about a lab working on a treatment for the coronavirus-caused disease, chances are good that it’s using reagents, or substances that cause chemical reactions, made by MilliporeSigma in St. Louis. Many vaccine scientists are using cell lines and culture media — the broth in which cells are grown — developed here in MilliporeSigma labs.